Donors at risk: Impaired glucose tolerance

Nephrology

Volumn 15, Issue SUPPL. 1, 2010, Pages

  Boudville, Neil ^a   Isbel, Nicole ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIABETIC NEPHROPATHY; DISEASE COURSE; GLUCOSE BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; KIDNEY DONOR; KIDNEY TRANSPLANTATION; LIVING DONOR; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SHORT SURVEY; ARTICLE; DIABETES MELLITUS; GLUCOSE INTOLERANCE; INCIDENCE; NEPHRECTOMY; PRACTICE GUIDELINE; RISK FACTOR;

CARDIOVASCULAR DISEASES; DIABETES MELLITUS; GLUCOSE INTOLERANCE; HUMANS; INCIDENCE; KIDNEY TRANSPLANTATION; LIVING DONORS; NEPHRECTOMY; RISK FACTORS;

EID: 84855461204     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2009.01222.x     Document Type: Short Survey

References (27)

1. Gabir MM, Hanson RL, Dabelea D et al. The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes. Diabetes Care 2000 23 : 1108 1112.
2. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet. Med. 1998 15 : 539 553.
3. Gall MA, Rossing P, Skott P et al. Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1991 34 : 655 661.
4. Torffvit O, Agardh CD. The impact of metabolic and blood pressure control on incidence and progression of nephropathy: A 10-year study of 385 type 2 diabetic patients. J. Diabetes Complications 2001 15 : 307 313.
5. Anavekar NS, McMurray JJ, Velazquez EJ et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N. Engl. J. Med. 2004 351 : 1285 1295.
6. Boudville N, Prasad GV, Knoll G et al. Meta-analysis: Risk for hypertension in living kidney donors. Ann. Intern. Med. 2006 145 : 185 196.
7. Wareham NJ, Byrne CD, Williams R et al. Fasting proinsulin concentrations predict the development of type 2 diabetes. Diabetes Care 1999 22 : 262 270.
8. Yudkin JS, Alberti KG, McLarty DG et al. Impaired glucose tolerance. BMJ 1990 301 : 397 402.
9. Coutinho M, Gerstein HC, Wang Y et al. The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95 783 individuals followed for 12.4 years. Diabetes Care 1999 22 : 233 240.
10. Decode Study Group, European Diabetes Epidemiology Group. Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases? Diabetes Care 2003 26 : 688 696.
11. Albareda M, Caballero A, Badell G et al. Diabetes and abnormal glucose tolerance in women with previous gestational diabetes. Diabetes Care 2003 26 : 1199 1205.
12. Morris RD, Rimm DL, Hartz AJ et al. Obesity and heredity in the etiology of non-insulin-dependent diabetes mellitus in 32 662 adult white women. Am. J. Epidemiol. 1989 130 : 112 121.
13. Fehrman-Ekholm I, Duner F, Brink B et al. No evidence of accelerated loss of kidney function in living kidney donors: Results from a cross-sectional follow-up. Transplantation 2001 72 : 444 449.
14. Ramcharan T, Matas AJ. Long-term (20-37 years) follow-up of living kidney donors. Am. J. Transplant. 2002 2 : 959 964.
15. Iglesias-Marquez RA, Calderon S, Santiago-Delpin EA et al. The health of living kidney donors 20 years after donation. Transplant. Proc. 2001 33 : 2041 2042.
16. Eberhard OK, Kliem V, Offner G et al. Assessment of long-term risks for living related kidney donors by 24-h blood pressure monitoring and testing for microalbuminuria. Clin. Transplant. 1997 11 : 415 419.
17. Hakim RM, Goldszer RC, Brenner BM. Hypertension and proteinuria: Long-term sequelae of uninephrectomy in humans. Kidney Int. 1984 25 : 930 936.
18. Miller IJ, Suthanthiran M, Riggio RR et al. Impact of renal donation. Long-term clinical and biochemical follow-up of living donors in a single center. Am. J. Med. 1985 79 : 201 208.
19. Rizvi SA, Naqvi SA, Hussain Z et al. Living-related pediatric renal transplants: A single-center experience from a developing country. Pediatr. Transplant. 2002 6 : 101 110.
20. Talseth T, Fauchald P, Skrede S et al. Long-term blood pressure and renal function in kidney donors. Kidney Int. 1986 29 : 1072 1076.
21. Undurraga A, Roessler E, Arcos O et al. Long-term follow-up of renal donors. Transplant. Proc. 1998 30 : 2283 2285.
22. Watnick TJ, Jenkins RR, Rackoff P et al. Microalbuminuria and hypertension in long-term renal donors. Transplantation 1988 45 : 59 65.
23. Williams SL, Oler J, Jorkasky DK. Long-term renal function in kidney donors: A comparison of donors and their siblings. Ann. Intern. Med. 1986 105 : 1 8.
24. Raile K, Galler A, Hofer S et al. Diabetic nephropathy in 27 805 children, adolescents, and adults with type 1 diabetes: Effect of diabetes duration, A1C, hypertension, dyslipidemia, diabetes onset, and sex. Diabetes Care 2007 30 : 2523 2528.
25. Adler AI, Stevens RJ, Manley SE et al. Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int. 2003 63 : 225 232.
26. Edelstein SL, Knowler WC, Bain RP et al. Predictors of progression from impaired glucose tolerance to NIDDM: An analysis of six prospective studies. Diabetes 1997 46 : 701 710.
27. de Vegt F, Dekker JM, Jager A et al. Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: The Hoorn Study. JAMA 2001 285 : 2109 2113.